Inovio Pharma Stock
Price
Target price
-
-
-
-
-
?11.09
WKN: A115GK / Symbol: INO / Name: Inovio Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Inovio Pharma Stock
Currently there is a rather negative sentiment for Inovio Pharma with 2 Buy predictions and 4 Sell predictions..
However, we have a potential of 1967.67% for Inovio Pharma as the target price of 11 € is above the current price of 0.53 €.
For the coming years our community has positive and negative things to say abot the Inovio Pharma stock. Criterium "Business model" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Inovio Pharma in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Inovio Pharma vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Inovio Pharma | - | - | - | - | - | - | - |
Ardelyx Inc. | 0.400% | -6.042% | -11.918% | 60.952% | -12.284% | 211.043% | - |
Evolus Inc | 1.890% | 1.887% | 10.204% | 64.885% | 19.337% | 13.089% | - |
Coherus Bioscien. | -1.880% | -0.956% | -2.907% | -61.062% | -50.559% | -86.459% | -90.599% |
Comments
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at Stephens. They set an "overweight" rating and a $20.00 price target on the stock.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Show more
Ratings data for INO provided by MarketBeat